Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 46.12% is in line with its 5-year average of 45.08%, near the high end of its 5-year range (33.44%–47.81%).
0.65% below its 12-month average of 46.42%.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-06-30): 46.46%.
GROSS MARGIN
46.12%
GROSS MARGIN AVG TTM
46.42%
GROSS MARGIN AVG 3Y
45.16%
GROSS MARGIN AVG 5Y
45.08%
GROSS MARGIN AVG 10Y
46.28%
GROSS MARGIN AVG 15Y
47.57%
GROSS MARGIN AVG 20Y
48.75%
CURRENT VS TTM AVG
-0.65%
CURRENT VS 3Y AVG
+2.13%
CURRENT VS 5Y AVG
+2.31%
CURRENT VS 10Y AVG
-0.35%
CURRENT VS 15Y AVG
-3.06%
CURRENT VS 20Y AVG
-5.40%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-21.82%
vs the sector median at left
Becton, Dickinson and Company
Market Cap
$49.00B
Gross Margin
46.12%
TTM Avg
46.42%
3Y Avg
45.16%
5Y Avg
45.08%
Market Cap
$48.58B
Gross Margin
77.98%
TTM Avg
78.79%
3Y Avg
78.80%
5Y Avg
77.78%
Market Cap
$43.20B
Gross Margin
52.47%
TTM Avg
50.27%
3Y Avg
48.88%
5Y Avg
48.29%
Market Cap
$43.09B
Gross Margin
26.23%
TTM Avg
30.59%
3Y Avg
32.75%
5Y Avg
33.07%
Market Cap
$41.50B
Gross Margin
53.73%
TTM Avg
53.36%
3Y Avg
52.95%
5Y Avg
53.14%
Market Cap
$39.81B
Gross Margin
62.45%
TTM Avg
61.42%
3Y Avg
60.55%
5Y Avg
59.83%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Becton, Dickinson and Company (BDX) | $49.00B | 46.12% | 46.42% | 45.16% | 45.08% |
| Humana Inc. (HUM)vs › | $49.21B | 13.65% | 14.54% | 16.14% | 17.03% |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | 77.98% | 78.79% | 78.80% | 77.78% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 52.47% | 50.27% | 48.88% | 48.29% |
| IQVIA Holdings Inc. (IQV)vs › | $43.09B | 26.23% | 30.59% | 32.75% | 33.07% |
| Cardinal Health, Inc. (CAH)vs › | $54.94B | 3.84% | 3.75% | 3.54% | 3.65% |
| Agilent Technologies, Inc. (A)vs › | $41.50B | 53.73% | 53.36% | 52.95% | 53.14% |
| Moderna, Inc. (MRNA)vs › | $57.13B | 55.35% | 54.80% | 53.09% | 65.45% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $39.81B | 62.45% | 61.42% | 60.55% | 59.83% |
| Cencora, Inc. (COR)vs › | $62.57B | 3.71% | 3.06% | 3.07% | 2.95% |
Gross Margin
46.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 46.46% |
| 2026-03-31 | 45.69% |
| 2025-12-31 | 44.63% |
| 2025-09-30 | 47.50% |
| 2025-06-30 | 47.81% |
| 2025-03-31 | 42.81% |
| 2024-12-31 | 43.25% |
| 2024-09-30 | 45.74% |
| 2024-06-30 | 46.23% |
| 2024-03-31 | 45.67% |
| 2023-12-31 | 43.07% |
| 2023-09-30 | 33.44% |
| 2023-06-30 | 43.05% |
| 2023-03-31 | 46.36% |
| 2022-12-31 | 46.51% |
| 2022-09-30 | 43.63% |
| 2022-06-30 | 44.54% |
| 2022-03-31 | 44.48% |
| 2021-12-31 | 47.05% |
| 2021-09-30 | 44.54% |
| 2021-06-30 | 42.50% |
| 2021-03-31 | 45.77% |
| 2020-12-31 | 51.40% |
| 2020-09-30 | 46.11% |
| 2020-06-30 | 43.06% |
| 2020-03-31 | 40.75% |
| 2019-12-31 | 46.82% |
| 2019-09-30 | 49.43% |
| 2019-06-30 | 47.68% |
| 2019-03-31 | 47.06% |
| 2018-12-31 | 47.43% |
| 2018-09-30 | 47.50% |
| 2018-06-30 | 47.12% |
| 2018-03-31 | 38.04% |
| 2017-12-31 | 50.42% |
| 2017-09-30 | 49.08% |
| 2017-06-30 | 49.52% |
| 2017-03-31 | 48.23% |
| 2016-12-31 | 49.69% |
| 2016-09-30 | 48.03% |
| 2016-06-30 | 48.37% |
| 2016-03-31 | 48.35% |
| 2015-12-31 | 47.15% |
| 2015-09-30 | 46.27% |
| 2015-06-30 | 37.63% |
| 2015-03-31 | 51.00% |
| 2014-12-31 | 50.95% |
| 2014-09-30 | 50.05% |
| 2014-06-30 | 51.51% |
| 2014-03-31 | 50.82% |
| 2013-12-31 | 51.36% |
| 2013-09-30 | 51.73% |
| 2013-06-30 | 51.63% |
| 2013-03-31 | 50.90% |
| 2012-12-31 | 52.95% |
| 2012-09-30 | 50.88% |
| 2012-06-30 | 52.16% |
| 2012-03-31 | 51.21% |
| 2011-12-31 | 50.84% |
| 2011-09-30 | 51.27% |
| 2011-06-30 | 52.73% |
| 2011-03-31 | 52.10% |
| 2010-12-31 | 53.02% |
| 2010-09-30 | 52.04% |
| 2010-06-30 | 51.75% |
| 2010-03-31 | 51.96% |
| 2009-12-31 | 52.14% |
| 2009-09-30 | 51.95% |
| 2009-06-30 | 52.75% |
| 2009-03-31 | 51.92% |
| 2008-12-31 | 53.65% |
| 2008-09-30 | 51.43% |
| 2008-06-30 | 50.88% |
| 2008-03-31 | 51.13% |
| 2007-12-31 | 51.35% |
| 2007-09-30 | 51.10% |
| 2007-06-30 | 51.50% |
| 2007-03-31 | 51.49% |
| 2006-12-31 | 52.79% |
| 2006-09-30 | 48.41% |
| 2006-06-30 | 50.63% |
| 2006-03-31 | 50.94% |
| 2005-12-31 | 52.22% |
| 2005-09-30 | 51.96% |
| 2005-06-30 | 50.28% |
| 2005-03-31 | 50.35% |
| 2004-12-31 | 50.75% |
| 2004-09-30 | 50.52% |
| 2004-06-30 | 50.46% |
| 2004-03-31 | 49.78% |
| 2003-12-31 | 46.48% |
| 2003-09-30 | 50.26% |
| 2003-06-30 | 46.59% |
| 2003-03-31 | 48.99% |
| 2002-12-31 | 47.70% |
| 2002-09-30 | 49.22% |
